Clinical trial
Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
NCT02922179 is registered in ClinicalTrials.gov with Biologics & Biosimilars Collective Intelligence Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics
- Lead sponsor
- Biologics & Biosimilars Collective Intelligence Consortium
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2011
- Completion date
- January 31, 2019
- Enrollment
- 103,951 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes